| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A call to move beyond MSM-centric framing in mpox research
|
Coelho, Camila H
|
|
|
25 |
9 |
p. e495-e496
|
artikel
|
| 2 |
A rare case of rabies-like Australian bat lyssavirus infection
|
Lateef, Saman
|
|
|
25 |
9 |
p. e498
|
artikel
|
| 3 |
Balancing safety and efficacy: new insights on primaquine for malaria transmission blocking
|
Hänscheid, Thomas
|
|
|
25 |
9 |
p. 948-949
|
artikel
|
| 4 |
Battling antimicrobial resistance: new guidance and insights
|
Moore, David P
|
|
|
25 |
9 |
p. 957-958
|
artikel
|
| 5 |
Correction to Lancet Infect Dis 2025; published online July 14. https://doi.org/10.1016/S1473-3099(25)00344-5
|
|
|
|
25 |
9 |
p. e497
|
artikel
|
| 6 |
Correction to Lancet Infect Dis 2025; published online June 24. https://doi.org/10.1016/S1473-3099(25)00283-X
|
|
|
|
25 |
9 |
p. e497
|
artikel
|
| 7 |
Designing better systems to navigate the sepsis–antimicrobial stewardship tension
|
Lounsbury, Olivia
|
|
|
25 |
9 |
p. e527-e532
|
artikel
|
| 8 |
Effectiveness of integrated vector management on the incidence of dengue in urban Malaysia: a cluster-randomised controlled trial
|
Saadatian-Elahi, Mitra
|
|
|
25 |
9 |
p. 977-985
|
artikel
|
| 9 |
Estimated undertreatment of carbapenem-resistant Gram-negative bacterial infections in eight low-income and middle-income countries: a modelling study
|
Mishra, Anant
|
|
|
25 |
9 |
p. 1011-1019
|
artikel
|
| 10 |
Evaluation for fungal pulmonary infections is essential in suspected tuberculosis relapse
|
Pasqualotto, Alessandro C
|
|
|
25 |
9 |
p. e493
|
artikel
|
| 11 |
Evaluation for fungal pulmonary infections is essential in suspected tuberculosis relapse – Authors' reply
|
Paton, Nicholas I
|
|
|
25 |
9 |
p. e494
|
artikel
|
| 12 |
George Louis Drusano
|
Bagcchi, Sanjeet
|
|
|
25 |
9 |
p. 961
|
artikel
|
| 13 |
Global immunisation coverage not where it should be
|
Burki, Talha
|
|
|
25 |
9 |
p. e501-e502
|
artikel
|
| 14 |
Immunogenicity and safety of different immunisation schedules of the VLA15 Lyme borreliosis vaccine candidate in adults, adolescents, and children: a randomised, observer-blind, placebo-controlled, phase 2 trial
|
Wagner, Laura
|
|
|
25 |
9 |
p. 986-999
|
artikel
|
| 15 |
Infectious disease surveillance update
|
McQuillan, Cahal
|
|
|
25 |
9 |
p. e502
|
artikel
|
| 16 |
Lyme borreliosis vaccine VLA15 tested safe and immunogenic in children and adolescents
|
Hajdusek, Ondrej
|
|
|
25 |
9 |
p. 951-952
|
artikel
|
| 17 |
Managing urban Aedes mosquito populations and Aedes-borne diseases: trial design and effect dilution
|
Abad-Franch, Fernando
|
|
|
25 |
9 |
p. 949-951
|
artikel
|
| 18 |
Maternal vaccination to prevent severe RSV disease in infants
|
Zar, Heather J
|
|
|
25 |
9 |
p. 958-960
|
artikel
|
| 19 |
Meru Sheel—promoting vaccines and emergency responses
|
Kirby, Tony
|
|
|
25 |
9 |
p. 962
|
artikel
|
| 20 |
Missing the target for antibiotic access
|
Ashley, Elizabeth A
|
|
|
25 |
9 |
p. 954-955
|
artikel
|
| 21 |
Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
|
|
|
|
25 |
9 |
p. 1000-1010
|
artikel
|
| 22 |
More evidence needed for maternal RSVpreF protection to age 6 months
|
Effler, Paul
|
|
|
25 |
9 |
p. e491
|
artikel
|
| 23 |
More evidence needed for maternal RSVpreF protection to age 6 months – Authors' reply
|
Rearte, Analia
|
|
|
25 |
9 |
p. e492
|
artikel
|
| 24 |
New advances for drug-resistant tuberculosis
|
The Lancet Infectious Diseases,
|
|
|
25 |
9 |
p. 947
|
artikel
|
| 25 |
New lenacapavir guidelines from WHO
|
Kirby, Tony
|
|
|
25 |
9 |
p. e500
|
artikel
|
| 26 |
Pandemic politics in Mexico
|
Dunsmuir, Henrietta
|
|
|
25 |
9 |
p. 963
|
artikel
|
| 27 |
Racism in the COVID-19 pandemic
|
Johnson, Anna
|
|
|
25 |
9 |
p. 964
|
artikel
|
| 28 |
Real-world effectiveness of RSVpreF vaccination during pregnancy against RSV-associated lower respiratory tract disease leading to hospitalisation in infants during the 2024 RSV season in Argentina (BERNI study): a multicentre, retrospective, test-negative, case–control study
|
Pérez Marc, Gonzalo
|
|
|
25 |
9 |
p. 1044-1054
|
artikel
|
| 29 |
Research in brief
|
Venkatesan, Priya
|
|
|
25 |
9 |
p. e503
|
artikel
|
| 30 |
Revisiting oral antivirals for COVID-19 in the hospital setting
|
Lui, Grace C Y
|
|
|
25 |
9 |
p. 952-954
|
artikel
|
| 31 |
Safety and efficacy of single-dose primaquine to interrupt Plasmodium falciparum malaria transmission in children compared with adults: a systematic review and individual patient data meta-analysis
|
Yilma, Daniel
|
|
|
25 |
9 |
p. 965-976
|
artikel
|
| 32 |
Severe enteric fever with septic multiorgan failure and gastrointestinal bleeding after travel to Nigeria
|
Mester, Patricia
|
|
|
25 |
9 |
p. e540-e541
|
artikel
|
| 33 |
Suriname certified malaria-free
|
Jesudason, Timothy
|
|
|
25 |
9 |
p. e499
|
artikel
|
| 34 |
The effect of disease transmission on time-aggregated treatment efficacy estimates: a critical analysis of factors influencing the RTS,S and R21 malaria vaccine phase 3 trials
|
Macià, Dídac
|
|
|
25 |
9 |
p. e516-e526
|
artikel
|
| 35 |
The foretold Oropouche fever epidemic
|
Romero-Alvarez, Daniel
|
|
|
25 |
9 |
p. 955-957
|
artikel
|
| 36 |
The pharmacokinetics of antibiotics in patients with obesity: a systematic review and consensus guidelines for dose adjustments
|
Märtson, Anne-Grete
|
|
|
25 |
9 |
p. e504-e515
|
artikel
|
| 37 |
The spatiotemporal ecology of Oropouche virus across Latin America: a multidisciplinary, laboratory-based, modelling study
|
Fischer, Carlo
|
|
|
25 |
9 |
p. 1020-1032
|
artikel
|
| 38 |
The WHO Bacterial Priority Pathogens List 2024: a prioritisation study to guide research, development, and public health strategies against antimicrobial resistance
|
Sati, Hatim
|
|
|
25 |
9 |
p. 1033-1043
|
artikel
|
| 39 |
Urachal actinomycosis mimicking a urachal adenocarcinoma: case report and systematic review
|
Medina, Camilo
|
|
|
25 |
9 |
p. e533-e539
|
artikel
|
Tijdschrift beschrijving